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Abstract
Background: To determine the effects of supplemental fish oil (FO) on resting metabolic rate (RMR), body
composition, and cortisol production in healthy adults.
Methods: A total of 44 men and women (34 ± 13y, mean+SD) participated in the study. All testing was performed first
thing in the morning following an overnight fast. Baseline measurements of RMR were measured using indirect
calorimetry using a facemask, and body composition was measured using air displacement plethysmography. Saliva
was collected via passive drool and analyzed for cortisol concentration using ELISA. Following baseline testing, subjects
were randomly assigned in a double blind manner to one of two groups: 4 g/d of Safflower Oil (SO); or 4 g/d of FO
supplying 1,600 mg/d eicosapentaenoic acid (EPA) and 800 mg/d docosahexaenoic acid (DHA). All tests were repeated
following 6 wk of treatment. Pre to post differences were analyzed using a treatment X time repeated measures
ANOVA, and correlations were analyzed using Pearson’sr .
Results: Compared to the SO group, there was a significant increase in fat free mass following treatment with FO
(FO = +0.5 ± 0.5 kg, SO = -0.1 ± 1.2 kg, p = 0.03), a significant reduction in fat mass (FO = -0.5 ± 1.3 kg, SO = +0.2
± 1.2 kg, p = 0.04), and a tendency for a decrease in body fat percentage (FO = -0.4 ± 1.3% body fat, SO = +0. 3 ±
1.5% body fat, p = 0.08). No significant differences were observed for body mass (FO = 0.0 ± 0.9 kg, SO = +0.2 ±
0.8 kg), RMR (FO = +17 ± 260 kcal, SO = -62 ± 184 kcal) or respiratory exchange ratio (FO = -0.02 ± 0.09, SO =
+0.02 ± 0.05). There was a tendency for salivary cortisol to decrease in the FO group (FO = -0.064 ± 0.142 μg/dL,
SO = +0.016 ± 0.272 μg/dL, p = 0.11). There was a significant correlation in the FO group between change in
cortisol and change in fat free mass (r = -0.504, p = 0.02) and fat mass (r = 0.661, p = 0.001).
Conclusion: 6 wk of supplementation with FO significantly increased lean mass and decreased fat mass. These
changes were significantly correlated with a reduction in salivary cortisol following FO treatment.
Background
It is generally believed that a high-fat diet is a contribut-
ing factor to excess body fat accumulation due to the
greater energy density of fat and the relative inability of
the body to increase fat oxidation in the presence of
over consumption of fats [1,2]. However, several rodent
studies have shown clearly that diets rich in omega 3
fatty acids, specifically eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), which are found in large
amounts in the oil from cold-water fish, lead to
significantly lower total body fat stores vs diets rich in
other fatty acids [3-7]. The exact mechanism(s) respon-
sible for this phenomenon are not completely under-
stood, but there are several possible explanations. For
example, EPA and DHA are very effective at suppressing
lipogenic gene expression [8,9], thereby limiting the
synthesis of lipids. EPA and DHA have also been found
to increase the oxidation of lipids as a result of an
increase in carnitine acyltransferase I (CAT 1) activity
[10,11], which allows greater fatty acid transport across
the inner mitochondrial matrix via the carnitine-acylcar-
nitine translocase mechanism [12]. Additionally, EPA
can increase mitochondrial lipid oxidation indirectly by
inhibiting acetyl-CoA carboxylase [13], which is the
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is a potent inhibitor of CAT I [14]. Moreover, EPA and
DHA can also decrease the sensitivity of CAT I to malo-
nyl CoA [11,15] which may allow a higher rate of lipid
oxidation across a variety of different metabolic states. It
is also possible that omega 3 fatty acids may influence
total body lipid accretion by increasing thermogenesis as
a result of increased activity of uncoupling proteins and
peroxisomes [16], and/or by increasing lean body mass
[3,5], which would indirectly increase thermogenesis.
Although there is some disagreement in the literature,
there appears to be a negative effect of the stress hor-
mone cortisol on body composition [17,18]. The well-
documented association between Cushing’s disease and
obesity [19] clearly shows that conditions that signifi-
cantly increase cortisol levels can increase fat accretion.
However, it is not known if treatments that lower corti-
sol levels can positively impact body composition. There
is limited evidence that fish oil supplementation can
reduce cortisol levels [20], which raises the possibility
that the consumption of fish oil could decrease body fat
% by decreasing cortisol levels. To date, no study has
examined the relationship between salivary cortisol and
body composition following treatment with fish oil.
D e s p i t et h em e c h a n i s t i cd a t aa n dr e s u l t si nr o d e n t s ,
very little is known about the effects of omega 3 fatty
acids on body composition and metabolic rate in
humans. In the first study using humans, Couet et al.
[21] found that when 6 g/d of visible dietary fat was
replaced with 6 g/d of fish oil for 3 wk, there was a sig-
nificant increase in fat oxidation as measured by RER,
and a concomitant decrease in total body fat as mea-
sured by dual energy X-ray absorptiometry. There was
also an increase in the resting metabolic rate, but this
was no longer evident when the observed slight increase
in lean mass during the fish oil treatment was accounted
for, perhaps suggesting that fish oil may increase RMR
by increasing lean mass. More recently, Hill et al. [22]
found that supplementing the diet with fish oil signifi-
cantly reduced fat mass compared to a control group
supplemented with sunflower oil. Similarly, Thorsdottir
et al. [23] found that including fish, or fish oil supple-
ments, in a hypoenergetic diet resulted in greater weight
loss in young overweight men compared to a hypoener-
getic diet that did not include fish or fish oil.
The aim of the present study was 1) to determine the
effects of supplemental fish oil on body composition
and resting metabolic rate in healthy adults, and 2) to
determine the effects of supplemental fish oil on morn-
ing salivary cortisol concentrations, and determine if
there is a relationship between changes in salivary corti-
sol concentrations and changes in body composition fol-
lowing fish oil treatment.
Methods
Prior to all testing, approval for the study was obtained
from the institutional review board at Gettysburg Col-
lege and written informed consent was obtained from
all subjects.
Healthy adults (18-55y) were recruited through flyers
posted at Gettysburg College and surrounding commu-
nity. Individuals who ate fatty fish at least 3 times a
month, or were supplementing their diet with omega 3
fatty acids, or had a known metabolic or endocrine dis-
order were excluded. Subjects were healthy and active,
but not engaged in consistent, systematic exercise train-
ing. In total, 44 individuals volunteered to participate
(Table 1). Subjects were asked to maintain their current
diet and exercise practices throughout the study.
Experimental Protocol
Subjects reported to the laboratory first thing in the
morning following a 10-12 ho v e r n i g h tf a s tf o rR M R
determination using open circuit indirect calorimetry
(n = 26) and body composition assessment using air dis-
placement via the Bod Pod® (n = 44). Following these
tests, a saliva sample was taken via passive drool and
later analyzed for cortisol content. Subjects were then
randomly assigned in a double blind manner to one of
two groups:
Safflower oil (SO): 4 g/d of safflower oil (Genuine
Health Corporation, Toronto, Ontario, CA) adminis-
tered in 4 enteric-coated capsules (each capsule pro-
vided 1 g of cold pressed, high linoleic acid,
safflower oil).
Fish oil (FO):4g / dc o n c e n t r a t e df i s ho i l( o 3 m e g a
extra strength, Genuine Health Corporation, Tor-
onto, Ontario, CA) administered in 4 enteric-coated
capsules (each capsule provided 400 mg EPA and
200 mg DHA).
Subjects took 2 capsules with breakfast and 2 capsules
with dinner for a 6 wk period. All testing was repeated
following 6 wk of supplementation.
Body Composition
Body composition was assessed by whole body densito-
metry using air displacement via the Bod Pod® (Life Mea-
surements, Concord, CA). All testing was done in
accordance with the manufacturer’s instructions as
detailed elsewhere [24]. Briefly, subjects were tested wear-
ing only tight fitting clothing (swimsuit or undergar-
ments) and an acrylic swim cap. The subjects wore the
exact same clothing for all testing. Thoracic gas volume
was estimated for all subjects using a predictive equation
integral to the Bod Pod® software. The calculated value
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estimate body composition. A complete body composi-
tion measurement was performed twice, and if the body
fat % was within 0.05% the two tests were averaged. If
the two tests were not within 0.05% agreement, a third
test was performed and the average of 3 complete trials
was used for all body composition variables. All testing
was completed first thing in the morning following a 10
h overnight fast (water intake was allowed).
Resting Metabolic Rate (n = 24)
For logistical reasons, metabolic testing was only per-
formed on the first twelve subjects from each group (n =
24). Subjects refrained from caffeine consumption and vig-
orous exercise for 24 h prior to the resting metabolic rate
(RMR) test. The subjects kept a detailed record of their
food intake for the day prior to testing, and this was used
to duplicate the diet for the day prior to all subsequent
tests. Subjects transported themselves to the lab with the
provision that they did not walk more than 100 meters
total for their commute. Subjects rested in the supine posi-
tion in a darkened room covered with a light blanket. A
rubber face mask was used to collect expired gases for
analysis via open circuit indirect calorimetry using a Med-
graphics Ultima Cardio II breath-by-breath system that
was calibrated prior to each test according to manufac-
turers specifications. (Medical Graphics Corporation, St.
Paul, MN, USA). While the subjects rested quietly, data
were collected for 40 min. The final 20 min of data col-
lected was averaged and 24 h energy expenditure was cal-
culated using the thermal equivalent of O2 consumed
based on a non-protein RQ table [26].
Salivary analysis
Subjects rinsed their mouth with water prior to all saliva
collections to minimize contamination of the samples.
Saliva was collected in a polypropylene vial via passive
drool through a short straw and stored at -80°C until
analysis. Prior to analysis, samples were thawed and cen-
trifuged at 10,000 g for 20 minutes to remove mucins
and analyzed for cortisol concentration using a commer-
cially available enzyme immunoassay kit (Salimetrics,
State College, PA, USA). Salivary cortisol is a sensitive
marker of activation the hypothalamus-pituitary-adrenal
system’s response to stress and correlates very well with
blood cortisol concentrations [27].
Statistical Analysis
Data were analyzed using the Statistical Package for the
Social Sciences version 13 (SPSS Inc., Chicago, IL). A
treatment by time, repeated measures ANOVA was
used to evaluate significant differences, and a standard
pearson’s r was used to evaluate correlations. For all
analysis, the alpha level was set at p ≤ 0.05.
Table 1 Pre and Post values following 6 weeks of treatment with 4 g/d of safflower oil, or 4 g/d of fish oil
Safflower Oil Fish Oil
Pre Post Post-Pre
Difference
Pre Post Post-Pre
Difference
Sex
Male (n) 8 6
Female (n) 14 16
Age (y) 35 ± 14y
(29;41)
33 ± 13y
(27;39)
Weight (kg) 71.1 ± 15.2
(64.7;77.5)
71.3 ± 15.3
(65.1;77.6)
0.2 ± 0.8
(-0.2;0.6)
71.3 ± 14.4
(65.1;77.6)
71.3 ± 13.7
(65.1;77.6)
0.0 ± 0.9
(-0.4;0.4)
Body Fat (%) 27.7 ± 10.6
(23.0;32.4)
28.0 ± 10.8
(23.2;32.8)
0.3 ± 1.5†
(-0.4;1.0)
30.5 ± 7.7
(26.7;32.5)
30.1 ± 7.6
(26.3;33.9)
-0.4 ± 1.3†
(-1.2;0.2)
Fat Mass (kg) 19.7 ± 9.7
(15.4;24.0)
19.9 ± 9.9
(15.5;24.3)
0.2 ± 1.2*
(-0.3;0.7)
22.3 ± 8.2
(18.3;25.7)
21.8 ± 7.6
(18.2;25.0)
-0.5 ± 1.3*
(-1.1;0.1)
Fat Free Mass (kg) 50.5 ± 11.9
(45.2;55.5)
50.4 ± 12.3
(45.0;55.8)
-0.1 ± 1.2**
(-0.6;0.4)
50.1 ± 11.7
(45.1;55.1)
50.6 ± 11.9
(45.5;55.6)
0.5 ± 0.5**
(0.3;0.8)
Salivary Cortisol (μg/dL) 0.305 ± 0.240
(0.212;0.399)
0.321 ± 0.311
(0.217;0.425)
0.016 ± 0.272
(-0.108;0.140)
0.270 ± 0.179
(0.179;0.361)
0.206 ± 0.131
(0.104;0.308)
-0.064 ± 0.142
(-0.127;-0.002)
RMR (24 h Kcal); n = 26 1290 ± 295
(1103;1477)
1228 ± 277
(1053;1400)
-62 ± 184
(-179;55)
1335 ± 213
(1200;1470)
1352 ± 323
(1147;1557)
17 ± 260
(-148;152)
RER; n = 26 0.809 ± 0.052
(0.776;0.842)
0.832 ± 0.41
(0.806;0.858)
0.023 ± 0.54
(-0.011;0.057)
0.841 ± 0.59
(0.804;0878)
0.822 ± 0.48
(0.791;0.853)
-0.019 ± 0.85
(-0.073;0.035)
Data are expressed as means ± SD (95% confidence interval). Data were analyzed using a treatment X time repeated measures ANOVA
* significant treatment X time interaction, p = 0.04
** significant treatment X time interaction, p = 0.03
† treatment X time interaction, p = 0.08
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A total of 47 individuals volunteered to participate in
this study. Two individuals withdrew from the study cit-
ing personal time conflicts, and one participant with-
drew from the study as a result of a possible reaction to
the safflower oil capsules. In general, both treatments
were very well tolerated and no other side effects were
noted for either group. Of particular importance, the
enteric coating of the fish oil capsules prevented “fish
burps,” which are a common side effect often experi-
enced with fish oil supplementation. A total of 44 sub-
jects completed the study (Table 1).
Body Composition
Results from the body composition testing are presented
in Table 1. There were no significant differences
observed for body mass between the treatments (SO =
0.2 ± 0.8 kg; FO = 0.0 ± 0.9 kg; p = 0.52). However,
there was a significant treatment by time interaction
observed for fat free mass which means the change in
fat free mass over time was significantly different
between the treatments (Figure 1: SO = -0.1 ± 1.2 kg;
FO = +0.5 ± 0.5 kg; p = 0.03). Similarly, there was a sig-
nificant treatment by time interaction for fat mass as
w e l l( F i g u r e1 :S O=0 . 2±1 . 2k g ;F O=- 0 . 5±1 . 3k g ;p
= 0.04). Percent body fat also tended to change differ-
ently over time between the treatments (SO = 0.3 ±
1.5%; FO = -0.4 ± 1.3%; p = 0.08).
Salivary Cortisol Concentrations
There was a tendency for salivary cortisol concentrations
to change differently over time between the two treat-
m e n t s( S O=0 . 0 1 6±0 . 2 7 2μg/dL; FO = -0.072 ± 0.142
μg/dL; p = 0.11). However, when a repeated measures t
test was performed on the Pre and Post scores of each
group independently, the SO change was not significant
(p = 0.79), but the Post score was significantly lower than
the Pre score in the FO group (p = 0.04). It is very likely
that the reduced statistical power of the omnibus F used
in the repeated measures ANOVA resulted in a type II
error, and the reduction in salivary cortisol concentra-
tions following fish oil supplementation is a real effect. In
support of this, the 95% confidence interval of the Pre-
Post difference in salivary cortisol concentration for the
fish oil group (table 1) contains only negative values
(-0.127 to -0.002 μg/dL), whereas the 95% confidence
interval for the safflower oil group is centered around a
mean difference value of essentially zero (-0.108 to 0.14
μg/dL). Taken together, these additional statistics suggest
that the reduction in salivary cortisol concentration
observed in the fish oil group is a real effect.
T h ec h a n g ei ns a l i v a r yc o r t i s o lc o n c e n t r a t i o ni nt h e
FO group was significantly correlated with the change
in % body fat (r = 0.638, p = 0.001), the change in fat
free mass (r = -0.504, p = 0.02) as well as the change in
fat mass (r = 0.661, p = 0.001). No significant correla-
tions were observed in the SO group between the
change in salivary cortisol concentration and the change
in % body fat (r = -0.321; p = 0.17), change in fat free
mass (r = 0.007; p = 0.98), or the change in fat mass
(r = -0.309; p = 0.19).
Metabolic Data
No significant differences between groups were observed
over time for resting metabolic rate (SO = -62 ± 184
kcal, FO = 17 ± 260 kcal; p = 0.40), or for the respira-
tory exchange ratio (SO = 0.023 ± 0.54; FO = -0.019 ±
0.85, p = 0.16).
Discussion
The results of this study showed that 6 weeks of supple-
mental fish oil significantly increased lean mass, and sig-
nificantly reduced fat mass in healthy adults. This is in
agreement with Couet et al. [21], who observed a signifi-
cant 0.88 kg reduction in fat mass, and a non-significant
0.20 kg increase in lean mass following 3 weeks of an
increased consumption of fish oil. In their study, they
added fish oil to the diet, but kept total fat and energy
constant between the treatments. In the present study,
the fish oil was added on top of an ad libitum diet, with
instructions given to the subjects to maintain their nor-
mal dietary patterns throughout the study. Similarly,
Hill et al [22] found a significant reduction in fat mass
following 12 weeks of supplementation with fish oil in
overweight subjects. They also observed an increase in
lean mass in the fish oil group, however, like the data
reported by Couet et al. [21], it did not reach
Figure 1 Change in fat mass and fat free mass following 6 wk
of treatment with either 4 g/d of safflower oil (SO), or 4 g/d of
fish oil (FO). Data are means ± SEM. * significant treatment X
time interaction, p = 0.04. ** significant treatment X time
interaction, p = 0.03
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supplementation with fish oil, or inclusion of fish in an
energy-restricted diet resulted in significantly greater
weight loss in young men. Additionally, they found that
young men taking the fish oil supplements had a signifi-
cantly greater reduction in waist circumference com-
pared to the control group, or the group that increased
their dietary intake of fish.
Unlike the Couet et al. study [21], we did not observe
an increase in RMR, or a decrease in RER following fish
oil treatment. The failure to find an increase in RMR
following fish oil treatment is hard to explain given the
significant increase in lean mass observed in the present
study. Several studies have shown that lean mass is the
largest determinant of RMR [28-30], and decreasing
lean mass decreases RMR [31], while increasing lean
mass increases RMR [32]. Therefore, it would be
expected that the increase in lean mass would corre-
spond to an increased RMR following fish oil treatment.
In the Couet et al. study [21], metabolic data were mea-
sured for 45 min following a 90 min rest period. This is
al o n g e rt i m ep e r i o dt h a nt h e4 0m i nu s e di nt h ep r e -
sent study. However, it is doubtful that this methodolo-
gical difference between the studies contributed to the
differing effects observed for RMR and RER values since
recent studies have shown that very short rest periods
(as little as 5 min) produce reproducible results that
correlate extremely well with RMR measures made over
much longer time periods [33,34]. It is also unlikely that
the use of a subset (n = 24) of the total subject popula-
tion can explain the failure to observe any metabolic
changes since analysis of the 24 subjects found that they
responded similar to the entire group in regards to body
composition changes. It remains unclear why the
increased lean mass observed following fish oil treat-
ment did not correspond to an increase in RMR.
Intuitively it would make sense that if fat mass was
reduced, but resting metabolic rate did not change fol-
lowing fish oil treatment, then the amount of calories
coming from the oxidation of fatty acids should be
increased. However, this was not the case in the present
study. Although there was an absolute reduction in the
RER following fish oil treatment (which would indicate
an increased oxidation of fatty acids), the difference was
not statistically significant. While it is possible that a
type II error was committed and the reduction in RER
was a real effect, it is also possible that the fish oil treat-
ment increased fat oxidation at other times during the
day such as during exercise [35], or during the post-
prandial period [36].
A potential shortcoming of the present study was not
using dietary records tom o n i t o rt h es u b j e c t s ’ intake
during the study. Although there are several potential
problems with the use of dietary records (for a review of
inaccuracies with self-recorded diet records see [37]),
they would have provided us with some insight into the
dietary habits of the subjects during the study. It there-
fore remains a possibility that the fish oil supplements
resulted in the subjects changing their normal dietary
habits. Although increasing dietary fat does not gener-
ally cause a decrease in voluntary fat intake [38], it has
been shown that fish oil may reduce appetite [39],
which could have led to the subjects consuming less
total calories during the study. While a reduction in
volitional food intake would explain the observed reduc-
tion in fat mass following fish oil treatment, it does not
explain the increase in lean mass we observed.
Although other studies have observed a significant
[3,5], or insignificant [21,22], increase in lean mass fol-
lowing fish oil treatment, to date no study has deter-
mined the mechanism by which dietary fish oil causes
an increased accretion of lean mass. One possibility lies
in the well-documented ability of dietary omega 3 fatty
acids to reduce inflammatory cytokines [40], since
inflammatory cytokines have the ability to increase pro-
tein degradation mainly by activating the ATP-ubiqui-
tin-dependent pathway [41-45]. It is possible then, that
dietary fish oil is simply decreasing the breakdown of
protein tissue caused by inflammatory cytokines, and
this results in an increased accretion of protein over
time.
An alternative possibility is that fish oil supplementa-
tion was able to increase lean mass by reducing cortisol
levels since it is well established that cortisol increases
protein catabolism [46-49]. The significant negative cor-
relation (r = -0.504, p = 0.02) observed in the fish oil
group between the change in lean mass and the change
in salivary cortisol concentrations would support this
hypothesis. Although other studies have observed a
decrease in cortisol levels following fish oil consumption
[20], the exact mechanism(s) responsible are currently
unknown. However, it is possible that the reduction of
IL-6 as a result of fish oil consumption [50] is causing a
reduction in cortisol production since it has been shown
that IL-6 induces increases in cortisol levels [51,52]. It is
unclear whether it is the well-documented ability of fish
oil to reduce inflammatory cytokines, the reduction in
cortisol, or a combination of both, that resulted in the
increased lean mass observed in the present study fol-
lowing fish oil treatment. More work is needed to deter-
mine the mechanism(s) responsible for the accretion of
lean mass following fish oil consumption.
The role of cortisol in obesity is poorly understood.
Excessive cortisol levels, such as those observed in
patients with Cushing’s disease, results in substantial fat
mass gains - especially in the abdominal region [17,19].
However, there is disagreement between studies about
the relationship between values of cortisol that are
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Nevertheless, several studies have shown an association
with higher levels of cortisol and fat mass [53-58]. In
the present study, there was a significant correlation
between the change in salivary cortisol and the change
in fat mass following fish oil treatment (r = 0.661, p =
0.001). Recent work by Purnell et al. [59] has shown
that a reduction in fat mass as a result of dieting does
not lower cortisol production, which would suggest that
the relationship observed in the present study between
salivary cortisol and fat mass was not simply a result of
the reduction in fat mass. However, further work is
needed to determine exactly how the reduction in corti-
sol levels may have influenced fat loss observed in the
FO group.
In conclusion, 6 weeks of supplemental fish oil signifi-
cantly increased lean mass, and significantly reduced fat
mass in healthy adults. Given the short duration of this
study, it is unclear how these changes would impact
long-term body composition changes and more research
is needed to determine the impact of chronic fish oil
supplementation on long-term body composition. The
reduction in salivary cortisol following fish oil treatment
was significantly correlated with the increased fat free
mass and the decreased fat mass observed. To the best
of our knowledge, this is the first time that this associa-
tion has been described in the literature. Since higher
salivary cortisol levels are associated with higher mortal-
ity rates [60], the reduction in salivary cortisol levels
observed in the present study following fish oil supple-
mentation likely has significant implications beyond
positive changes in body composition.
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